Navigation Links
First evidence that prenatal exposure to famine may lead to persistent epigenetic changes
Date:10/30/2008

rmation," says L.H. Lumey, MD, MPH, PhD, associate clinical professor of Epidemiology at the Mailman School of Public Health and senior author. "If there are indeed relationships between adverse conditions during development and adult health, then these epigenetic changes might provide a mechanism to explain the link." Ezra Susser, MD, DrPH, co-author, and Anna Cheskis Gelman and Murray Charles Gelman Professor and chair of Epidemiology at the Mailman School, noted, "These findings are particularly intriguing in light of our reports on increased rates of schizophrenia after early gestational exposure to famine." Drs. Lumey and Susser are also leaders of the Imprints Center for Genetic and Environmental Lifecourse Studies at the Mailman School, which includes the Dutch Famine Study as one of its affiliated studies.

The findings also show that birth weight is not a good marker for individuals with changes in methylation. Epigenetic differences were found among individuals who were exposed to famine early in gestation who have normal birth weights. For comparison purposes, the researchers also studied individuals who were exposed late in gestation and who therefore had lower birth weights. They did not see methylation changes in this group however. The study used sibling controls to avoid many potential study biases.

"Our study illustrates that to monitor the crucial stages of early development, we can not rely on birth weight alone as an indicator of maternal nutrition. We must use our knowledge of the crucial events that took place during that period," observes Dr. Lumey. As the next step, the Leiden group led by Drs. Heijmans and Slagboom will examine with Dr. Lumey the effect of famine on other human genes. They are also interested in the effect of other specific exposures during early development, including folic acid supplementation around conception as these may have an effect on methylation in the developing fetus.

"Understanding
'/>"/>

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Obama Puts Healthcare, Economic Relief for Middle Class First in Prime-Time Special
2. WPI receives award from Homeland Security Department to advance first-responder location
3. First Results from Hospital Trials Show Pathogens Stay Close to Patients
4. NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders
5. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
6. Evolution Physical Therapy First Clinic in Southern California to Introduce NASA-Designed Anti-Gravity Treadmill for Public Use
7. Fight begins to eradicate fatal parasite; first vaccines delivered following major funding award
8. Mylans Matrix First-to-File on Generic Version of Vfend(R) Antifungal
9. P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth
10. Cardinal Health Reports First Quarter Results
11. Four Companies Are First to Achieve Accreditation Under Two New URAC Pharmacy Quality Management(SM) Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... new three-drug combination has shown in a phase 1/2 ... regimen" in the treatment of patients newly diagnosed with ... bone marrow, say researchers from Dana-Farber Cancer Institute. , ... the 66 patients treated with the drug combination in ... good partial response rate" in the phase 2 population, ...
(Date:12/5/2009)... Blood Cancer Is Most Challenging-- ,, PHILADELPHIA ... identified specific genes, dubbed partner genes, that fuse with ... in infants. By more accurately defining specific partner genes, ... from particular treatments. ,, Oncologists also aim to ...
(Date:12/5/2009)... Midbrook,s advanced Technology Center helps companies develop and test their cleaning ... in a variety of industries and solve problems for customers relating ... ... (Vocus) December 5, 2009 -- Midbrook, Inc , a Jackson, ...
(Date:12/4/2009)... Systems (NYSE: VAR ) announced today that its ... of Stockholders for February 11, 2010 with a record date ... the Crowne Plaza Cabana Hotel, 4290 El Camino Real, Palo ... be webcast by Thomson Financial and can be accessed at ...
(Date:12/4/2009)... Holdings, Ltd (NYSE: AWH ) today announced ... Sennott, Executive Vice,President and Chief Corporate Strategy Officer, will ... Conference being held at the Goldman,Sachs Conference Center in ... About Allied World Assurance Company ...
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
... MA--The National Institutes of Health (NIH) has awarded one ... 2008 to a team based at Boston University Medical ... (BMC). These awards, together with 12 CTSAs awarded in ... of an NIH effort to build a national consortium ...
... the focus of the Staying Sharp session on June 3 ... recognized series, the program will emphasize successful aging, including how ... future cognitive function; and the importance of clinical trials and ... member Marwan N. Sabbagh will sign copies of his book, ...
... Pa., May 29 The Pennsylvania,Department of Health today ... 31,observance of "World No Tobacco Day," which is designed ... "Exposure to secondhand smoke causes disease and premature death ... Calvin B.,Johnson. "I encourage all Pennsylvania smokers to set ...
... Ensure Patients Receive High-Value Health Care, WASHINGTON, ... care spending and improve the quality of patient ... Insurance Plans (AHIP) was,implemented. PricewaterhouseCoopers reviewed AHIP,s proposals ... fully implemented, the nation,s,total health care expenditures could ...
... Vanessa Carlton to Help ... Cancer Leader, WASHINGTON, May 29 Breast cancer ... Carlton will join Susan G. Komen for the Cure(R) ... activities leading up to the,19th annual Susan G. Komen ...
... Access by Breaking Through Barriers, NEWPORT NEWS, ... Patient Advocate Foundation today announced a strategic,collaboration that ... families,quick access to timely information and specialized patient ... lives of cancer,patients nationwide who are facing access ...
Other Medicine News:Health News:BUMC, BMC receives Clinical and Translational Science Award from NIH 2Health News:AHIP Outlines Plan to Reduce Health Care Costs by $145 Billion 2Health News:AHIP Outlines Plan to Reduce Health Care Costs by $145 Billion 3Health News:AHIP Outlines Plan to Reduce Health Care Costs by $145 Billion 4Health News:Susan G. Komen for the Cure(R) Celebrity Ambassadors to Convene in Nation's Capital to Help Race for the Cure, End Breast Cancer Forever 2Health News:American Cancer Society, Patient Advocate Foundation Announce Free, Personalized Assistance for Cancer Patients 2Health News:American Cancer Society, Patient Advocate Foundation Announce Free, Personalized Assistance for Cancer Patients 3
(Date:12/4/2009)... Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) ... Amended Plan of Reorganization and related amended Disclosure Statement with ... ,, A hearing to consider the adequacy of ... with the hearing on the confirmation of the Plan scheduled ...
(Date:12/4/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Principal investigators will discuss the data presentations surrounding carfilzomib ... the 51st American Society of Hematology (ASH) Annual Meeting. ... a.m. ET on Monday, December 7, 2009. The ...
(Date:12/4/2009)... Shared Imaging, LLC, an independent provider of CT, ... hospitals and healthcare providers, is excited to announce ... Ambulatory Health Care, a nationally-recognized, prestigious gold seal ... care. Shared Imaging accreditation is system-wide for its ...
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2New research program BioInterfaces launched 8742 1New research program BioInterfaces launched 8742 2Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 1Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 2Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 1Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 2Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 3
... CAMBRIDGE, Mass., and BERLIN, Sept. 26 ,Genzyme Corporation ... AG, Germany,today announced that the first patient has ... 3 trials examining the safety and efficacy of ... The CARE-MS I trial (Comparison of Alemtuzumab and ...
... 26 Innocoll, Inc., a privately-held,specialty pharmaceutical company, ... clinical development programs and specialty,pharmaceutical operations: - ... in 2007., - GENTAMICIN ... multi-centered clinical trials for the ...
Other Medicine Technology:Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 2Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 3Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 4Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 5Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 6Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 2Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 3Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 4Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 5Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 6
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
Seamlessly integrates with the i2000SR to form a state-of-the-art immunochemistry platform, the ci8200. Flexibility to prioritize STAT, automated rerun/dilution, and reflex testing over routines to e...
... and controls interchangeable with other Roche/Hitachi ... training costs. Consistent patient results throughout ... handling. 70 positions for routine, STAT ... volumes. Intermix sample types. Intermix 5 ...
Modular Pre-Analytics is an integral component of the new modular systems platform which combines pre-analytics, clinical chemistry and immunochemistry....
Medicine Products: